Quarterly report · Q2
3154.TEDINET S100RJV3
Period2021-07-01 → 2021-12-31
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100NCZC.
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥112.3bn | 2021-07-01 → 2021-12-31 | Cons. | Net sales |
| Revenue | ¥213.3bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥102.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2021-07-01 → 2021-12-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2020-07-01 → 2020-12-31 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2021-07-01 → 2021-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-07-01 → 2020-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2021-07-01 → 2021-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2020-07-01 → 2020-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥952m | 2020-07-01 → 2020-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss |
| Net income | ¥952m | 2020-07-01 → 2020-12-31 | Cons. | Profit loss |
| Total assets | ¥95.3bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥84.5bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥86.2bn | at 2020-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥78.1bn | at 2021-12-31 | Cons. | Liabilities |
| Total liabilities | ¥68.6bn | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.2bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥15.8bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥14.7bn | at 2020-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.7bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.6bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.6bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.0bn | at 2020-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.5bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥3.5bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.8bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥554m | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.4bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.6bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6.0bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥65.37 | 2021-07-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.93 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.81 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.69 | 2020-07-01 → 2020-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.4 | 2020-10-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥65.34 | 2021-07-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥94.15 | 2020-07-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.59 | 2020-07-01 → 2020-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 18.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.0% | at 2020-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-12-31 | −¥3.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥109.6bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥109.6bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥4.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥278m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2021-12-31 | ¥112.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2021-12-31 | ¥112.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2021-12-31 | ¥5.0bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2020-12-31 | −¥2.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2020-07-01 → 2020-12-31 | ¥99.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2020-07-01 → 2020-12-31 | ¥99.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2020-07-01 → 2020-12-31 | ¥3.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2020-07-01 → 2020-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2020-07-01 → 2020-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2020-07-01 → 2020-12-31 | ¥358m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-07-01 → 2020-12-31 | ¥102.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-07-01 → 2020-12-31 | ¥102.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-07-01 → 2020-12-31 | ¥4.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 541
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for loss on guarantees | Prior1YearInstant | 109013000 | JPY |
| Provision for loss on guarantees | CurrentQuarterInstant | 100804000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1304353000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 1344802000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 65569000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 65676000 | JPY |
| Provision for share based compensation ncl | Prior1YearInstant | - | JPY |
| Provision for share based compensation ncl | CurrentQuarterInstant | 17052000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | - | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 50009000 | JPY |
| Other ncl | Prior1YearInstant | 1060419000 | JPY |
| Other ncl | CurrentQuarterInstant | 1186166000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 7942755000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 8863618000 | JPY |
| Liabilities | Prior1YearInstant | 68636761000 | JPY |
| Liabilities | CurrentQuarterInstant | 78073795000 | JPY |
| Capital stock | Prior1YearInstant | 1285270000 | JPY |
| Capital stock | CurrentQuarterInstant | 1344769000 | JPY |
| Capital surplus | Prior1YearInstant | 2611508000 | JPY |
| Capital surplus | CurrentQuarterInstant | 2671008000 | JPY |
| Retained earnings | Prior1YearInstant | 10200316000 | JPY |
| Retained earnings | CurrentQuarterInstant | 11172615000 | JPY |
| Treasury stock | Prior1YearInstant | -450000 | JPY |
| Treasury stock | CurrentQuarterInstant | -450000 | JPY |
| Shareholders equity | Prior1YearInstant | 14096645000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 15187942000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1839196000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 2072595000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -92688000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -84296000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 1746508000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 1988298000 | JPY |
| Net assets | Prior1YearInstant | 15843153000 | JPY |
| Net assets | CurrentQuarterInstant | 17176241000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 84479914000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 95250036000 | JPY |
| Net sales | Prior1YTDDuration | 102043700000 | JPY |
| Net sales | CurrentYTDDuration | 112291320000 | JPY |
| Cost of sales | Prior1YTDDuration | 89998842000 | JPY |
| Cost of sales | CurrentYTDDuration | 98826138000 | JPY |
| Gross profit | Prior1YTDDuration | 12044857000 | JPY |
| Gross profit | CurrentYTDDuration | 13465182000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -8792000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -9809000 | JPY |
| Provision for share based compensation sga | Prior1YTDDuration | 7308000 | JPY |
| Provision for share based compensation sga | CurrentYTDDuration | -3397000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 4594124000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 4884181000 | JPY |
| Employees bonuses sga | Prior1YTDDuration | 1091981000 | JPY |
| Employees bonuses sga | CurrentYTDDuration | 1196970000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |